Verrica Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
15.12.23
/
50%
€5.10
Target price
15.12.24
€9.18
Performance (%)
-86.93%
End price
16.12.24
€0.67
Summary
This prediction ended on 16.12.24 with a price of €0.67. The BUY prediction by Jefferies_Financial_ for Verrica Pharmaceuticals performed very badly with a performance of -86.93%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten